| Prev Close | 33.51 |
| Open | 33.51 |
| Day Low/High | 33.44 / 34.45 |
| 52 Wk Low/High | 27.88 / 43.08 |
| Volume | 45.84M |
Pfizer Inc. (PFE)
34.37
0.86
2.60
NYSE
| Exchange | NYSE |
| Shares Outstanding | 5577.63B |
| Market Cap | 187.91B |
| P/E Ratio | 23.58 |
| Div & Yield | N.A. (N.A) |
Let's Take a Look at Pfizer Partner BioNTech's Charts
Aggressive traders who have dug into the fundamentals of this German-based company could look to go long.
2 Energy Stocks With Promise: A Technical Look
Let's head to the oil patch for a look at Chevron and Pioneer Natural Resources.
The Thunder in South Florida Yesterday Was Not the Bad Weather - It Was the Sound of the Market's Pivot From Growth to Value
* Yesterday may have represented a classic "sell on the good news" * While many were cheering about the vaccine news, I was waiting to sell, red tickets in hand * Some stocks and sectors had a great year yesterday * And some stocks and sectors got s...
Vaccine Rotation, What I Bought and Sold, Stocks on Thin Ice, Apple's Event
What the Nasdaq experienced Monday is known not just as an 'Outside Day,' but an 'Outside Reversal,' and these can be dangerous.
Vaccine News Triggers Vicious Rotational Action
The Russell 2000 outperformed the Nasdaq by 5.2 percentage points on Monday -- the largest outperformance ever recorded between the two indices.
Injection of Vaccine Hope Spurs a Messy Rally
The sloppy day wasn't nearly as positive as you'd think based on the action in the Dow and S&P 500, and the question now is what comes next?
Jim Cramer: Even With New Covid Weapon, the Fight Goes On
We are going to win the war, but battles are still ahead. Here's how to invest in the meantime.
What Does a 3-Sigma Move Mean for Markets?
Ask yourself if anything has really changed.
A Dose of Good News Spurs a 'Buy Everything' Rally
Here's how to position yourself now that news of the Pfizer vaccine has landed, and what's happening with the 'haves,' 'have nots' and Treasuries.
Vaccine News Produces Overreactions in Both Directions
This is a very extended market that is now even more extended.
What the Vaccine News Means for Stocks and the Market
When the dust settles midweek, I believe we'll have a great feel for the longer-term outlook associated with the Pfizer news.
Resistance Levels Likely No Match for Vaccine Rally
Monday's vaccine news may well further improve the charts technically.
Pfizer's Ureka Moment and Why Winning Is Never Boring
The leaders now are suddenly the reopening stocks, while the work remotely and stay at home stocks are being sold.
Pfizer Vaccine Causes a Frenzy of Buying
The vaccine news marks a major turning point and the issue now is to navigate this rotation.
Have the Charts of Pfizer Changed Monday Morning?
Let's take a look amid the announcement that Pfizer's Covid-19 vaccine has progressed further.
My Election Day Wish, Tech Sector Performance, Trading Amazon and 6 Other Stocks
Here's to the removal of uncertainty -- and thousands of campaign signs on thousands of lawns in my neighborhood.
I'm Long Moderna and Here's Why
The focus when it comes to MRNA is the timing of mRNA-1273, the firm's two dose hopeful protection against Covid.
Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks
The 'work from home' or 'economic lockdown' trade is close to being back on.
Red Monday, Virus Rattles Market, Political Picture, Aerospace & Defense Stocks
This is a major earnings week, electoral risk is real, the virus is already slowing velocity, and the cavalry (fiscal policy) is not coming. Sometimes, circling the wagons is not the worst idea.
Pfizer Is Trading a Lot on Hopes Ahead of Earnings
Investors are not positioned for an upside move.
Politics and the Virus, Unpriced Risk, Monster Earnings
There is no stimulus deadline. There is no deal. There are only the games people play.
4 Straight Days, Troubling Trend?, Dollar Weakness, FDA Meets, Pfizer Vaccine
Several sessions over the past 10 days have seen increased trading volume at the NYSE, but not the Nasdaq, and for the S&P 500, but not the Nasdaq Composite. Is this professional risk reduction?
3 'Pick & Shovel' Stock Plays in Covid Vaccine Development
Investors are chasing every name that's developing a promising coronavirus vaccine. These stocks will be winners no matter which companies are successful.
Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade
Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.
Pelosi's Hardball Gambit, Playing Small Ball, Promising Vaccine Outlook
Plus, there's talk of a possible combination of Advanced Micro Devices and Xilinx.
Stimulus Repercussions, Is the Equities Rally Dead? Antitrust Action, Apple 5G
One day after deciding that we still could not confirm the market's uptrend, we are forced to ask the opposite.
DC Do-Over, October Volatility, Positive Technicals, Datadog Breakout, Moderna
Suddenly, both sides realize that they have played politics and the people had noticed. Not those two from Tuesday night. Thankfully.
Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.
Neither candidate seems to be the enemy of the market -- at least not yet.
